Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.44 - $11.21 $1,443 - $2,174
-194 Reduced 1.53%
12,476 $93,000
Q4 2023

Feb 14, 2024

SELL
$6.71 - $10.16 $51,170 - $77,480
-7,626 Reduced 37.57%
12,670 $117,000
Q3 2023

Nov 13, 2023

SELL
$9.35 - $14.32 $10,584 - $16,210
-1,132 Reduced 5.28%
20,296 $205,000
Q2 2023

Aug 11, 2023

SELL
$9.86 - $13.12 $44,872 - $59,709
-4,551 Reduced 17.52%
21,428 $267,000
Q1 2023

May 12, 2023

SELL
$10.23 - $14.76 $7,508 - $10,833
-734 Reduced 2.75%
25,979 $303,000
Q4 2022

Feb 14, 2023

BUY
$6.86 - $11.32 $93,316 - $153,985
13,603 Added 103.76%
26,713 $284,000
Q3 2022

Nov 10, 2022

BUY
$9.3 - $18.27 $121,923 - $239,519
13,110 New
13,110 $127,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.